VANGUARD GROUP INC 13D/13G Filings for TherapeuticsMD, Inc. (TXMD)

VANGUARD GROUP INC 13D and 13G filings for TherapeuticsMD, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-10
11:57 am
Sale
2020-12-3113GTherapeuticsMD, Inc.
TXMD
VANGUARD GROUP INC263,313
4.390%
-68,592decrease
(-20.67%)
Filing